Effect of adding daclatasvir in sofosbuvir-based therapy in genotype 3 hepatitis C: real-world experience in Pakistan. [electronic resource]
Producer: 20201001Description: 1035-1039 p. digitalISSN:- 1473-5687
- Antiviral Agents -- therapeutic use
- Carbamates
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- therapeutic use
- Incidence
- Male
- Middle Aged
- Pakistan -- epidemiology
- Pyrrolidines
- RNA, Viral -- genetics
- Retrospective Studies
- Sofosbuvir -- therapeutic use
- Treatment Outcome
- Valine -- analogs & derivatives
- Viral Load -- drug effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.